Clarity Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Clarity Pharmaceuticals has a total shareholder equity of A$53.1M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$58.2M and A$5.1M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
Interest coverage ratio | n/a |
Cash | AU$37.98m |
Equity | AU$53.06m |
Total liabilities | AU$5.11m |
Total assets | AU$58.17m |
Recent financial health updates
Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth
Jan 03We're Interested To See How Clarity Pharmaceuticals (ASX:CU6) Uses Its Cash Hoard To Grow
May 29Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth
Aug 24Here's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn Situation
Jan 13Recent updates
Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth
Jan 03We're Interested To See How Clarity Pharmaceuticals (ASX:CU6) Uses Its Cash Hoard To Grow
May 29Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth
Aug 24Here's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn Situation
Jan 13Financial Position Analysis
Short Term Liabilities: CU6's short term assets (A$57.6M) exceed its short term liabilities (A$4.9M).
Long Term Liabilities: CU6's short term assets (A$57.6M) exceed its long term liabilities (A$217.7K).
Debt to Equity History and Analysis
Debt Level: CU6 is debt free.
Reducing Debt: CU6 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CU6 has sufficient cash runway for 12 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: CU6 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 42.4% each year.